![Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity | Scientific Reports Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-80853-6/MediaObjects/41598_2020_80853_Fig1_HTML.png)
Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity | Scientific Reports
![Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration | Experimental Brain Research Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration | Experimental Brain Research](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00221-014-3961-6/MediaObjects/221_2014_3961_Fig1_HTML.gif)
Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration | Experimental Brain Research
![Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/ cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinoma | BMC Urology | Full Text Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/ cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinoma | BMC Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12894-022-01139-9/MediaObjects/12894_2022_1139_Fig2_HTML.png)
Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/ cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinoma | BMC Urology | Full Text
![Taj Pharma Group Under close cooperation between the formulation manufacturing division, active ingredient division and the technology development division for major generic formulations such as Cisplatin Injection BP; at Taj Pharma we Taj Pharma Group Under close cooperation between the formulation manufacturing division, active ingredient division and the technology development division for major generic formulations such as Cisplatin Injection BP; at Taj Pharma we](https://tajgenerics.com/wp-content/uploads/Cisplatin-injection-BP-10mg-10ml-Taj-Pharmaceuticals-scaled.jpg)
Taj Pharma Group Under close cooperation between the formulation manufacturing division, active ingredient division and the technology development division for major generic formulations such as Cisplatin Injection BP; at Taj Pharma we
![Pharmaceutics | Free Full-Text | Milnacipran Has an Antihyperalgesic Effect on Cisplatin-Induced Neuropathy Pharmaceutics | Free Full-Text | Milnacipran Has an Antihyperalgesic Effect on Cisplatin-Induced Neuropathy](https://www.mdpi.com/pharmaceutics/pharmaceutics-15-02218/article_deploy/html/images/pharmaceutics-15-02218-g001.png)
Pharmaceutics | Free Full-Text | Milnacipran Has an Antihyperalgesic Effect on Cisplatin-Induced Neuropathy
![Defining cisplatin eligibility in patients with muscle-invasive bladder cancer | Nature Reviews Urology Defining cisplatin eligibility in patients with muscle-invasive bladder cancer | Nature Reviews Urology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41585-020-00404-6/MediaObjects/41585_2020_404_Fig1_HTML.png)